Introduction: Children with RADs experience a lot of problems in their day to day activities. Respiratory Allergies pose the greatest stress on the children in most of the developed and developing countries. In India 15-20% population is suffering from RADs. There is no cure for RADs as per the Conventional Medical Science. Ayurvedic medicines can be a potential and effective alternative for the treatment against the RADs. Materials and methods: Double blind randomised controlled trial was conducted on 100 patients of RADand were given Drakshadi Yogfor 12 weeks. Results: In intergroup comparison extremely significant gain was seen in trial group (group A) over control group (group B) for nasal discharge, sneezing, nasal obstruction, itching of nose and eye, wheezing and inflammation of throat. Whereas for loss of smell, headache and cough very significant advantage was observed in trial group (group A) over group B. Significant gain was seen in trial group (group A) over control group (group B) for hoarseness of voice. Insignificant gain was found in trial group (group A) over control group (group B), for fever and dyspnea. Discussion: No adverse effect was observed. Thus, Drakshadi Yog can be recommended for the management of Respiratory Allergic Disorders of Children.
Introduction
Children with RADs experience a lot of problems in their day to day activities. Respiratory Allergies pose the greatest stress on the children in most of the developed and developing countries. Respiratory allergic disease are showing upward trend worldwide. In India 15-20% population is suffering from RADs 1 .Children with Respiratory Allergic Disorders experience frustration, anxiety and physical, social and emotional disturbances that affect their learning ability. The disorder contributes to headaches, fatigue, limits daily activities, interferes with sleep and leads to school absenteeism. There is no cure for RADs as per the Conventional Medical Science. Ayurvedic medicines can be a potential and effective alternative for the treatment against the RADS. Ayurvedic medicines are used for the treatment of allergic diseases globally so that people all over the world can keep faith on it on the basis of scientific evidences.
Aims and objectives 1. To assess the efficacy of "DRAKSHADI YOG" on Respiratory allergic disorders. 2. To provide the relief or improve previous symptoms. 3 . To restore normal airway function and to promote healthy life style. 
Material and methods

Administration of drug:
Selected patients were given Trial drug and placebo1ml/kg/day in 2-3 divided doses for 12 weeks.Follow up was done every 15 days during the trial and at the end of the treatment.
Assessment criteria:
For assessment of the efficacy of the trial therapy, following parameters were adopted-  Sore throat with pain and difficulty in food intake 2
 Sore throat with pain which interferes with intake of liquids too 3
Objectives
Following laboratory findings were assesseda) Peak Expiratory Flow Rate (PEFR) b) Laboratory parameters Blood -(T.L.C, D.L.C, HB%, TEC, IgE) U.S.G. if needed.
Statistical Analysis
Various observations made and results within groups obtained were computed statistically using Wilcoxon matched-pairs signed-ranks test and Mann whitney test and unpaired and paired t testto find out the significance of the values obtained and various conclusions were drawn accordingly.
Observation and results
Total 110 patients were registered for the present study. Out of them 10 patients dropped out and study was completed on 100 patients. The components of the study drug might have acted at various levels in breaking the pathogenesis of the allergic disorders. Some hampers the immediate hypersensitivity reaction by inhibiting histamine release, or by inhibiting mast cell degranulation as for e.g. Vitis vinifera andPiperlongum depletes histamine from bronchial and lung tissues.Mast cell inhibitory activity is possessed by Terminelia chebula and Piperlongum.On the other hand some are effective for late phase allergy owing to the inhibitory action on leukotrine systems as or by reducing the eosinophil count. e.g. Vitis vinifera andPiperlongum. The efficacy of trial drug in reducing the nasal discharge is because of the Vata and Kapha Shamaka qualityof the drug. The anti-allergic, anti-inflamatory and Rasayana (immunomodulator) effect of various ingredients is responsible for the overall relief in the symptoms, including nasal discharge, sneezing, itching etc. (e.g. Draksha, Yavasa, Haritiki and Pippali). Cough in RAD is mainly due to post-nasal dripping causing throat irritation. Improvement in cough may be because of pacification of Vata and KaphaDosha and removal of obstructing Kapha from the Pranavaha Srotas due to anti-tussive and mucolytic properties of the ingredients as Pippali.Expectorant action was also attributed to Yavasa because of flavonoids, tannins, sterols, triterpene, saponins and anthroquinones alkaloids. Relief from dyspnea and reduction in wheezing was because of relieving the obstruction in passage of Pranavayu by Samakapha. The probable action of drug was because of its KaphaVatahara effect and Ushna, TeeksnaGuna. The relief might be the result of bronchodilator action of Pippali. 2 Spasmolytic action of Pippali acts by inhibiting the contractile action of histamine by glycoside saponin. Terminelia chebula has potent mast cell stabilizing property also has anti histaminic effect by Ellagic acid Tannins Chebulagic acid. Nasal obstruction, throat inflammation, loss of smell and hoarseness of voice are because of edematous and later on inflammatory changes in various target organs in the disease process. The study drug showed significant anti-inflammatory effect. (e.g. Draksha, Yavasa and Pippali. Headache is mainly because of allergic sinusitis accompanying the RADs. Significant relief from headache after treatment was observed which might be due to anti-inflammatory properties of Draksha, Yavasa and Pippali. In addition, Vata Dosha get pacified and becomes responsible for the relief. Pippalialso proved to possess analgesic property. Mild inflammation due to allergic reaction showed marked relief. It may be because of proven anti-inflammatory activity of Draksha, Yavasa and Pippali. Increased Hb % after treatment is suggestive of the effect of trial drug in improving RasaDhatwagni owing to the effect of Haritiki,Pippali and thereby the quality of RaktaDhatu. In addition, the drug has Amapachaka and Srotoshodhaka effect. Thus, by cleansing the channels and by increasing the absorption, it has improved the appetite and digestive power of the patients. Improvement in the status of leucocyte count shows the anti-inflammatory activity of trial drug. It may be attributed to immunomodulatory and its antiinflammatory effect of various components such as Draksha, Yavasa and Pippali. Eosinophils are key effector cells of inflammatory response in RAD. Reduction in eosinophil and IgE is suggestive of potent anti-allergic and anti-inflammatory activity of the study drug such as Draksha, Yavasa and Pippali. Increased PEFR is suggestive of the fact that, trial drug could have modified the existing airflow limitation caused due to obstruction. Haritiki and Pippali have Deepana, Pachana and Amadosh hara properties. Thereby, the drug is helpful in restoring normal breathing. As Pippali and Haritiki act as Rasayan on Pranvahasrotas, it may have worked on quantitative and qualitative improvement of lung structure and function. The insignificant change in the condition of patient after follow up with respect to after treatment position is suggestive of requirement of long-term therapy. From this research work, it has been concluded that along with anti-allergic & bronchodilator effect, immunomodulatory regimen will play a key role in future therapies for allergic respiratory diseases. These treatment modalities may not only treat allergic disease, but also be beneficial in reducing the morbidity and mortality for which it is responsible. Psychological stress may be an additional environmental factor that worsens the oxidative toxicity 3 the ingredients like, Pippali by their anti-stress activity are responsible for regression of symptoms. Thus, overall improvement in the condition of the patient of the study group may be because of the multidimensional properties of the drug. (Vatakaphahara, Deepana, Pachana, and Vatanulomana properties), which are essential for breaking down pathogenesis of RAD. The main factor in this disease as in many other diseases is Ama, and the Deepana-Pachana properties of the drug will digest the Ama by improving the Jatharagni as well as Rasagni and Bhutagni. Furthermore, the Sothahara Karma of most of the contents will neutralize the Srotorodha in Pranavaha Srotasa due to Sotha created by Sama Vata.
Conclusion 11-15 years age group was the most affected group. Males were more susceptible to RADs as compared to females. Maximum numbers of cases were belonging to urban area and middle socio-economic status. Maximum number of cases exhibited seasonal manifestation. Hereditary influence is evident in RADs.The provocating factors observed were dust, smoke, seasonal changes, cold air, cold water, cloudy weather physical stress, spicy and oily food, sour food items and mental stress. Associated complaints found are snoring, serous otitis media, tonsillitis and migraine. The characteristic behavior and appearance were observed in the form of allergic shinners, nasal crease, allergic cluck, allergic salute and allergic gape. Kapha Vata Prakriti patients were found to be more susceptible for RADs. Maximum number of patients of the trial was under Mandagni. IgE level was found to be elevated in 86.00% and 90.00% in group A and B respectively. TEC level was found to be elevated in 90.00% and 88.00% in group A and B respectively. After treatment follow up study showed that research drug provides the long-term sustained relief. No adverse effect, of the study drug was observed during the study.
